Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals Ownership Summary

Eledon Pharmaceuticals is owned by 29.68% institutional investors, 1.40% insiders, and 68.92% retail investors. Bvf inc/il is the largest institutional shareholder, holding 10.53% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.15% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Eledon Pharmaceuticals	29.68%	1.40%	68.92%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	6.29M	10.53%	$21.33M
Ra capital management	3.57M	5.96%	$12.09M
Vanguard group	2.89M	5.57%	$11.93M
Sphera funds management	2.55M	4.91%	$10.51M
First light asset management	2.33M	3.90%	$7.89M
Blue owl capital lp	1.96M	3.77%	$8.07M
Woodline partners lp	1.67M	3.22%	$6.89M
Schonfeld strategic advisors	1.52M	2.92%	$6.24M
Ensign peak advisors	1.26M	2.44%	$5.21M
Nantahala capital management	1.14M	1.91%	$3.87M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sanofi	814.98K	1.93%	$3.36M
Sphera funds management	2.55M	1.90%	$10.51M
Blue owl capital lp	1.96M	1.86%	$8.07M
22nw, lp	636.36K	1.45%	$2.16M
Velan capital investment management lp	323.97K	1.13%	$1.10M
Cm management	275.00K	1.01%	$1.13M
First light asset management	2.33M	0.90%	$7.89M
Bvf inc/il	6.29M	0.87%	$21.33M
Awm investment company	1.10M	0.51%	$3.73M
Allostery investments lp	100.00K	0.49%	$339.00K

Top Buyers

Holder	Shares	% Assets	Change
Blue owl capital lp	1.96M	1.86%	1.96M
Vanguard group	2.89M	0.00%	1.33M
Sphera funds management	2.55M	1.90%	1.25M
Woodline partners lp	1.67M	0.05%	828.93K
Ensign peak advisors	1.26M	0.01%	821.92K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-2.36M
Frazier life sciences management	-	-	-1.18M
Point72 asset management	-	-	-1.09M
Zimmer partners, lp	750.00K	0.05%	-684.73K
Acuta capital partners	-	-	-235.75K

New Positions

Holder	Shares	% Assets	Change	Value
Blue owl capital lp	1.96M	1.86%	1.96M	$8.07M
Sanofi	814.98K	1.93%	814.98K	$3.36M
22nw, lp	636.36K	1.45%	636.36K	$2.16M
Boothbay fund management	341.92K	0.03%	341.92K	$1.41M
Inspire investing	194.69K	0.09%	194.69K	$802.12K

Sold Out

Holder	Change
Jpmorgan chase	-97.00
Wells fargo & company/mn	-189.00
Citadel advisors	-1.40K
Two sigma securities	-11.03K
Connor, clark & lunn investment management	-11.30K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	14	-81.82%	17,746,490	-53.88%	29	0.54%	4	-93.75%	4	100.00%
Dec 31, 2024	17	-48.48%	4,377,486	-76.32%	8	0.67%	12	-	-	-100.00%
Sep 30, 2024	33	6.45%	18,485,827	1.24%	35	0.96%	12	-42.86%	6	500.00%
Jun 30, 2024	31	3.33%	18,259,810	90.30%	60	3.88%	21	90.91%	1	-85.71%
Mar 31, 2024	30	3.45%	9,595,061	4.83%	39	4.25%	11	-8.33%	7	16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.88M	3.15%	-
Vanguard US Total Market Shares ETF	1.15M	1.92%	-
Vanguard Institutional Extnd Mkt Idx Tr	974.99K	1.63%	-
Fidelity Extended Market Index	330.69K	0.55%	5.05K
MEDICAL BioHealth EUR Acc	294.49K	0.49%	294.49K
Inspire Fidelis Multi Factor ETF	187.76K	0.31%	-
Extended Equity Market Fund K	121.50K	0.20%	372.00
IMC US Ultra Micro Cap	120.96K	0.20%	-
BlackRock Extended Equity Market K	79.41K	0.20%	-34.00
iShares Micro-Cap ETF	117.87K	0.20%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$440.49
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.10K
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.21K
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$1.95M
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$232.07

Insider Transactions Trends

Date	Buy	Sell
2035 Q1	-	-
2025 Q1	-	-
2024 Q4	3	-
2024 Q2	6	-
2023 Q4	-	-

ELDN Ownership FAQ

Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 29.68%, followed by 1.40% insiders and 68.92% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Eledon Pharmaceuticals falls below.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 10.53%), Ra capital management (3.57M shares, 5.96%), and Vanguard group (2.89M shares, 5.57%). Together, they hold 22.06% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sanofi is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.93% of its assets in 814.98K Eledon Pharmaceuticals shares, valued at 3.36M$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.15% of its total shares outstanding invested in 1.88M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools